Figure 1 (Penmenvy Spl Graphic 01)
Penmenvy Kit
Product Images NDC 58160-757
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Penmenvy (NDC 58160-757). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Glaxosmithkline Biologicals Sa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Penmenvy Spl Graphic 02)
Figure 3 (Penmenvy Spl Graphic 03)
Figure 4 (Penmenvy Spl Graphic 04)
Figure 5 (Penmenvy Spl Graphic 05)
Figure 6 (Penmenvy Spl Graphic 06)
Penmenvy 10 Dose Carton (Penmenvy Spl Graphic 07)
This text provides information about a vaccine called PENMENVY used for Meningococcal Groups A, B, C, W, and Y. It mentions that the Lyophilized MenACWY Component and MenB Component need to be combined before use. The vaccine is intended for individuals between 10 and 25 years of age and each dose is approximately 0.5 mL for intramuscular use. It includes 10 vials of Lyophiized MenACWY Component and 10 prefilled syringes of Men8 Component. Syringes with TIP-LOK feature are advised to be used with Luer Lock compatible needles, although needles are not included with the vaccine packaging.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
